dactinomycin has been researched along with ethylene glycol in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Králík, P; Vítek, JA | 1 |
| Fujimoto, N; Hayashi, Y; Inoue, K; Ohgusu, Y; Yuasa, H | 1 |
4 other study(ies) available for dactinomycin and ethylene glycol
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Effect of drugs affecting synthesis or degradation of connexin on onset or completion of ethylene glycol induced inhibition of intercellular gap junctional communication.
Topics: Animals; Bucladesine; Cell Line; Coloring Agents; Connexin 43; Connexins; Cricetinae; Cyclic AMP; Cycloheximide; Dactinomycin; Ethylene Glycol; Gap Junctions; Golgi Apparatus; Immunohistochemistry; Promoter Regions, Genetic; Protein Biosynthesis; Protein Synthesis Inhibitors; Time Factors; Transcription, Genetic | 2002 |
Enhanced uptake of glycerol by butyrate treatment in HCT-15 human colon cancer cell line.
Topics: Biological Transport, Active; Butyrates; Cell Line, Tumor; Colonic Neoplasms; Cycloheximide; Dactinomycin; Dose-Response Relationship, Drug; Ethylene Glycol; Glycerol; Glycols; Humans; Kinetics; Propylene Glycol; Sodium; Time Factors | 2007 |